FDA approval. approved for rosacea treatment – Finacea azelaic acid gel – Brief Article
Finacea. The U.S. Food and Drug Administration (FDA) has approved azelaic acid gel 15 percent (Finacea Gel) for the topical treatment of the inflammatory papules and pustules associated with mild to moderate rosacea.
Azelaic acid gel is the first new drug to be approved for treatment of rosacea in more than a decade. The exact mechanism of the drug is unclear, but clinical tests have shown that the drug interferes with the pathogenic events in rosacea. Treatment effects were reported after four weeks of therapy.
In clinical trials, the most frequently reported adverse effects related to azelaic acid gel included burning, tingling, and itching. Up to 10 percent of patients experienced dry skin and rash, the majority of which were mild.
COPYRIGHT 2003 American Academy of Family Physicians
COPYRIGHT 2003 Gale Group